SEC Form 5 · accession 0001387131-17-000718
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis J Carlo Ph.D.
Officer — President & CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 10, 2017 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 29, 2016 | G | 20,000 | $0.00 | D | 333,709 | I | By D. Carlo & A. Carlo Joint Living Trust |
| Common Stock | Dec 29, 2016 | G | 5,000 | $0.00 | D | 333,709 | I | By D. Carlo and A. Carlo Joint Living Trust |
Table II — derivative securities
No Table II lines on this filing.